POZZI, Valentina
 Distribuzione geografica
Continente #
NA - Nord America 3.033
EU - Europa 2.108
AS - Asia 744
AF - Africa 95
SA - Sud America 17
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 1
Totale 6.002
Nazione #
US - Stati Uniti d'America 3.022
IT - Italia 628
UA - Ucraina 369
SG - Singapore 338
IE - Irlanda 239
CN - Cina 200
SE - Svezia 196
DE - Germania 194
DK - Danimarca 140
FR - Francia 132
TR - Turchia 95
FI - Finlandia 93
KR - Corea 80
CI - Costa d'Avorio 79
GB - Regno Unito 56
IN - India 23
BR - Brasile 15
BE - Belgio 13
MA - Marocco 13
RO - Romania 13
CA - Canada 10
AT - Austria 9
PL - Polonia 5
EU - Europa 4
HR - Croazia 4
NL - Olanda 4
ES - Italia 2
JP - Giappone 2
LT - Lituania 2
SM - San Marino 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AO - Angola 1
AU - Australia 1
BD - Bangladesh 1
BJ - Benin 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
ET - Etiopia 1
GE - Georgia 1
HU - Ungheria 1
ID - Indonesia 1
MD - Moldavia 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
VN - Vietnam 1
Totale 6.002
Città #
Chandler 422
Jacksonville 382
Dublin 234
Boardman 232
Fairfield 202
Ashburn 200
Singapore 199
Wilmington 148
New York 122
Marche 113
Des Moines 93
Lawrence 84
Princeton 83
San Mateo 80
Abidjan 79
Houston 77
Seattle 76
Ann Arbor 69
Woodbridge 61
Cambridge 59
Turin 51
Ancona 39
Centro 37
San Diego 36
Beijing 30
Tolentino 27
Helsinki 23
Shanghai 23
Wuhan 20
Los Angeles 19
Washington 19
Milan 17
Berlin 15
London 14
Brussels 13
Guangzhou 13
Redmond 13
Rome 13
Brasov 12
Civitanova Marche 10
Wuxi 10
Dallas 9
Delhi 9
Pune 9
Vienna 9
Boydton 7
Cagliari 7
Jiaxing 7
Norwalk 7
Pesaro 7
Porto 7
Frederico Westphalen 6
Jinhua 6
Livorno 6
Aversa 5
Iesi 5
Quanzhou 5
Torino 5
Ascoli Piceno 4
Falconara Marittima 4
Genoa 4
Heze 4
Munich 4
Ottawa 4
Perugia 4
Radomsko 4
Seoul 4
Toronto 4
Torre Del Greco 4
Yiwu 4
Zagreb 4
Clifton 3
Foggia 3
Frankfurt am Main 3
Izmir 3
Loro Piceno 3
Montecassiano 3
Montelupone 3
Namhyang-dong 3
Pavia 3
Zibo 3
Amsterdam 2
Bhubaneswar 2
Borgo Maggiore 2
Brescia 2
Castiglione delle Stiviere 2
Cattolica 2
Chennai 2
Chiaravalle 2
Chiswick 2
Fort Collins 2
Imola 2
Lanuvio 2
Lauria 2
Monte San Vito 2
Naples 2
Nuremberg 2
Osimo 2
Pisa 2
Rieti 2
Totale 3.705
Nome #
Inflammatory cytokines patterns in the placenta of pregnancies complicated by HELLP syndrome. 121
Involvement of the oral cavity in psoriasis: results of a clinical study 118
Clinical performance and utility of a NNMT-based urine test for bladder cancer 107
Exploring the role of paraoxonase-2 in bladder cancer: analyses performed on tissue samples, urines and cell cultures 106
Cancer stem cell enrichment is associated with enhancement of nicotinamide N-methyltransferase expression 104
Betacyanins enhance vitexin-2-O-xyloside mediated inhibition of proliferation of T24 bladder cancer cells 102
Differential expression of nicotinamide N-methyltransferase in primary and recurrent ameloblastomas and odontogenic keratocysts 101
Gene expression profile of cytokines in patients with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with reduced conditioning. 98
Expression and prognostic significance of apoptotic genes in oral squamous cell carcinoma 97
Apoptosis pathway is involved in hemolysis, elevated liver enzyme, and low platelet (HELLP) syndrome and intrauterine growth restriction (IUGR). 94
Espressione della trombomodulina placentare negli aborti spontanei ricorrenti. 93
Involvement of transforming growth factor beta 1 in the transcriptional regulation of nicotinamide N-methyltransferase in clear cell renal cell carcinoma 92
Identification and Characterization of Cancer Stem Cells from Head and Neck Squamous Cell Carcinoma Cell Lines 91
RNA-Mediated Gene Silencing of Nicotinamide N-Methyltransferase Is Associated with Decreased Tumorigenicity in Human Oral Carcinoma Cells. 91
Nicotinamide N-methyltransferase in Non-small Cell Lung Cancer: Promising Results for Targeted Anti-cancer Therapy. 88
Role of nicotinamide N-methyltransferase in non-small cell lung cancer: in vitro effect of shRNA-mediated gene silencing on tumorigenicity 88
Inflammatory cytokines patterns in the placenta of pregnancies complicated by Hellp syndrome. 85
Bladder Cancer Chemosensitivity is Affected by Paraoxonase-2 Expression 84
Analysis of tissue and salivary nicotinamide N-methyltransferase in oral squamous cell carcinoma: basis for the development of a noninvasive diagnostic test for early-stage disease. 83
Inflammatory cytokines pattern in recurrent miscarriage. 81
Expression of extracellular matrix and adhesion proteins in pelvic organ prolapse 81
Pokemon proto-oncogene in oral cancer: potential role in the early phase of tumorigenesis. 80
Diagnostic and prognostic role of nicotinamide N-methyltransferase in cutaneous malignant melanoma 79
Paraoxonase-2 Silencing Enhances Sensitivity of A375 Melanoma Cells to Treatment with Cisplatin 79
Clues to apoptosis pathway involvement in hemolysis, elevated liver enzyme, and low platelet (HELLP) syndrome and intrauterine growth restriction (IUGR). 78
Upregulation of Tissue and Urinary Nicotinamide N-Methyltransferase in Bladder Cancer: Potential for the Development of a Urine-Based Diagnostic Test. 78
Nicotinamide N-methyltransferase in nonmelanoma skin cancers 78
Fattore di differenziamento eritrocitario (EDRF) nella patologia ostetrica. 77
Association of MiR-126 with Soluble Mesothelin-Related Peptides, a Marker for Malignant Mesothelioma. 76
Inhibiting proliferation in KB cancer cells by RNA interference-mediated knockdown of nicotinamide N-methyltransferase expression. 74
Nicotinamide N-methyltransferase: potential involvement in cutaneous malignant melanoma 74
Aspetti infiammatori, trombotici e immunitari nella biologia dell’aborto spontaneo ricorrente. 70
RNA-mediated gene silencing NNMT decreases tumorigenity in OSCC cells. 69
Cytokine expression profile of selected cell populations from patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation wih reduced conditioning. 68
Inflammatory cytokines pattern in recurrent miscarriage. 67
The involvement of inflammatory cytokines in the pathogenesis of recurrent miscarriage. 67
Evaluation of urinary Nicotinamide N-methyltransferase: a non-invasive diagnostic test for bladder cancer 67
Cancer stem cells from human tumor cell lines: molecular and phenotypic features 67
Structural Basis of Substrate Recognition in Human Nicotinamide N-Methyltransferase. 66
Enhanced expression of amyloid precursor protein in platelets from patients with Alzheimer’s disease and frontotemporal lobar degeneration. 66
Association of miR-126 with soluble mesothelin-related peptides: a novel marker for malignant mesothelioma. 65
CSCs selection, characterization and tumorigenic potential in OSCC. 65
Espressione di Pokemon nel carcinoma orale. 64
Periodontal Disease: An Oral Manifestation of Psoriasis or an Occasional Finding? 64
Enhanced expression of nicotinamide N-methyltransferase in non-small cell lung cancer: potential for the development of a targeted anticancer therapy. 63
Molecular and phenotypic characterization of cancer stem cells from human tumor cell lines 63
Identification and characterization of cancer stem cells from Head and Neck squamous cell carcinoma cell line Hep-2. 62
Natural extracts from the genus Beta and their cytotoxic activity on T24 human bladder cancer cells 62
L'enzima nicotinamide N-Metiltrasferasi: un nuovo marker diagnostico e target terapeutico nel carcinoma orale 61
Nicotinamide N-methyltransferase: a new potential biomarker for cutaneous malignant melanoma 59
Pattern di espressione placentare delle citochine infiammatorie nella HELLP syndrome. 58
Nicotinamide N-methyltransferase: a promising marker for oral cancer. 58
Neurotrophins and receptors pattern expression in placentas from pregnancies complicated by HELLP Syndrome and Intrauterine Growth Restriction (IUGR). 56
Paraoxonase 2 (PON2) expression in bladder cancer 56
Enhanced expression of paraoxonase 2 in human bladder cancer 56
Nicotinamide N-methyltransferase gene silencing enhances chemosensitivity of melanoma cell lines 56
Quantitative analysis of Nicotinamide N-methyltransferase expression in urine and tumour tissue of bladder cancer patients and its potential relevance for disease detection. 55
Salivary and tissue Nicotinamide N-methyltrasferase: potential use for early and non-invasive diagnosis of oral squamous cell carcinoma. 55
Nicotinamide N-Methyltransferase upregulation correlates with tumour differentiation in oral squamous cell carcinoma 54
Nicotinamide N-methyltransferase as potential diagnostic marker in patients with urinary bladder carcinoma: a real-time approach. 54
Characterization of cancer stem cells from larynx and bladder carcinoma cell lines 53
RNA-mediated gene silencing of nicotinamide N-methyltransferase is associated with decreased tumorigenicity in human oral carcinoma cells. 52
Nicotinamide N-Methyltransferase: a promising biomarker for early diagnosis and prognostic monitoring of oral squamous cell carcinoma. 51
Nicotinamide n-methyltransferase: a new diagnostic marker and therapeutic target for oral carcinoma. 51
The Double-Edged Sword of Oxidative Stress in Skin Damage and Melanoma: From Physiopathology to Therapeutical Approaches 51
Micro-RNA profiling identifies mir-126 as promising biomarker for prognosis and early detection of malignant mesothelioma. 50
The Utility of Nicotinamide N-Methyltransferase as a Potential Biomarker to Predict the Oncological Outcomes for Urological Cancers: An Update 50
Nicotinamide N-methyltransferase as effective diagnostic tool and promising therapeutic target for oral cancer. 49
L’enzima nicotinamide N-metiltrasferasi potenziale marcatore diagnostico e prognostico nel carcinoma renale. 48
Nicotinamide N-methyltransferase: a potential target molecule for effective therapy and early diagnosis of oral squamous cell carcinoma. 48
Inflammatory cytokines and receptors in placentas from pregnancies complicated by HELLP syndrome. 48
Paraoxonase-2: a novel molecular target to enhance chemosensitivity in melanoma and triple negative breast cancer cells 47
Profilo dell’espressione dei geni coinvolti nel pathway dell’apoptosi nel carcinoma orale. 46
Beyond Nicotinamide Metabolism: Potential Role of Nicotinamide N‐Methyltransferase as a Biomarker in Skin Cancers 46
Gene silencing of Nicotinamide N-methyltransferase in oral cancer cell lines: effects on tumor cell proliferation. 45
Tissue and salivary Nicotinamide N-Methyltransferase: promising results for early and non-invasive diagnosis of oral squamous cell carcinoma. 45
Quantitative analysis of NNMT mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection. 43
NNMT (nicotinamide N-methyltransferase). 43
Nicotinamide N-methyltransferase, a promising marker for human osteosarcoma 41
Epithelial Biological Response to Machined Titanium vs. PVD Zirconium-Coated Titanium: An In Vitro Study 41
Role Played by Paraoxonase-2 Enzyme in Cell Viability, Proliferation and Sensitivity to Chemotherapy of Oral Squamous Cell Carcinoma Cell Lines 40
Nicotinamide N-Methyltransferase as Promising Tool for Management of Gastrointestinal Neoplasms 40
Nicotinamide N-Methyltransferase as potential predictor of lymph node metastasis in Oral Squamous Cell Carcinoma. 40
Paraoxonase-2 is upregulated in triple negative breast cancer and contributes to tumor progression and chemoresistance 39
Nicotinamide N-methyltransferase: a new prognostic marker for oral squamous cell carcinoma. 37
Nicotinamide N-methyltransferase: a potential prognostic marker for oral squamous cell carcinoma. 36
Nicotinamide N-Methyltransferase in Head and Neck Tumors: A Comprehensive Review 36
Real-Time PCR analysis of NNMT expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection. 35
Recent Advances in the Management of Clear Cell Renal Cell Carcinoma: Novel Biomarkers and Targeted Therapies 33
Paraoxonase-2 expression in oral squamous cell carcinoma 33
Immunohistochemical expression of nicotinamide N-methyltransferase in lymph node metastases from cutaneous malignant melanoma 32
Gene silencing of Nicotinamide N-methyltransferase in oral cancer cell lines: effects on tumor cell proliferation. 32
Nicotinamide N-methyltransferase, a promising marker for human Merkel cell carcinoma 29
Role of paraoxonase-2 in triple-negative breast cancer: effect of shRNA-mediated gene silencing on cell proliferation and chemosensitivity 29
Paraoxonase-2 (PON2) is upregulated in triple negative breast cancer and contributes to the tumor progression and chemoresistance 28
FTIRM: an analytical approach to test the effectiveness of cisplatin treatment on PON2 silenced otscc cells 28
The Effect and the Potential Use of Magnetic–Dam Barrier in Guided Bone Regeneration: A Laboratory Study 24
Involvment of the enzyme nicotinamide N-methyltransferase in proliferation, invasive capacity and chemosensitivity of human osteosarcoma. 22
Role of nicotinamide N-methyltransferase in human osteosarcoma: in vitro effect of shRNA-mediated gene silencing on tumorigenicity 22
Enhanced expression of nicotinamide N-methyltransferase in human osteosarcoma: potential role in tumor growth and chemoresistance 21
Totale 6.155
Categoria #
all - tutte 39.683
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.683


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020361 0 0 0 0 0 6 84 14 85 6 67 99
2020/2021859 36 98 117 3 103 40 104 35 96 84 110 33
2021/2022628 29 167 14 23 0 19 23 59 33 60 49 152
2022/20231.409 100 170 101 119 83 194 18 88 336 13 121 66
2023/20241.136 169 26 82 126 145 183 14 34 20 90 52 195
2024/2025715 287 144 101 46 108 29 0 0 0 0 0 0
Totale 6.307